Melanie R Keats1, Yunsong Cui2, Scott A Grandy3, Louise Parker2. 1. School of Health and Human Performance, Dalhousie University, 6230 South Street, Halifax, NS, B3H 4R2, Canada. melanie.keats@dal.ca. 2. Population Cancer Research Program, Dalhousie University, 1494 Carlton Street, Halifax, NS, B3H 3B7, Canada. 3. School of Health and Human Performance, Dalhousie University, 6230 South Street, Halifax, NS, B3H 4R2, Canada.
Abstract
PURPOSE: The study aimed to examine the relationship between cardiovascular disease (CVD) and physical activity (PA) levels in cancer survivors (CS). METHODS: Using a nested, retrospective follow-up design, this study presents the self-reported prevalence of CVD in an Atlantic Canadian population-based cohort of 1526 CS and 6034 age-sex matched, non-cancer controls ranging from 35 to 69 years of age. Univariate and multiple logistic regression models were used to explore the association between CVD and PA. RESULTS: Overall, CS were 30% more likely to have ever experienced a CVD event than controls (OR = 1.3; 95% CI 1-1.7, p = .07). Survivors were also significantly more likely to report having hypertension (OR = 1.60; 95% CI 1.03-1.3, p = .02) and diabetes (OR = 1.27; 95% CI 1.03-1.16, p = .02). Compared to controls, CS were significantly less likely to engage in high levels of PA. For survivors, compared to those who were least physically active, the odds of having a CVD risk factor was 35% lower for those who were moderately active (OR = 0.65; 95% CI 0.48-0.88) and 45% lower in the most highly active group (OR = 0.55; 95% CI 0.4-0.73). For controls, the odds of having a CVD risk factor was 25% lower for those in the moderately active group (OR = 0.75; 95% CI 0.64-0.88) and 30% lower for those in the high active group (OR = 0.70; 95% CI 0.6-0.81). CONCLUSION: Low active survivors appear to be at a high risk of CVD-related comorbidity. IMPLICATIONS FOR CANCER SURVIVORS: PA is associated with lower CVD-related comorbidity in CS, suggesting that interventions directed at increasing PA should be implemented to improve long-term health outcomes.
PURPOSE: The study aimed to examine the relationship between cardiovascular disease (CVD) and physical activity (PA) levels in cancer survivors (CS). METHODS: Using a nested, retrospective follow-up design, this study presents the self-reported prevalence of CVD in an Atlantic Canadian population-based cohort of 1526 CS and 6034 age-sex matched, non-cancer controls ranging from 35 to 69 years of age. Univariate and multiple logistic regression models were used to explore the association between CVD and PA. RESULTS: Overall, CS were 30% more likely to have ever experienced a CVD event than controls (OR = 1.3; 95% CI 1-1.7, p = .07). Survivors were also significantly more likely to report having hypertension (OR = 1.60; 95% CI 1.03-1.3, p = .02) and diabetes (OR = 1.27; 95% CI 1.03-1.16, p = .02). Compared to controls, CS were significantly less likely to engage in high levels of PA. For survivors, compared to those who were least physically active, the odds of having a CVD risk factor was 35% lower for those who were moderately active (OR = 0.65; 95% CI 0.48-0.88) and 45% lower in the most highly active group (OR = 0.55; 95% CI 0.4-0.73). For controls, the odds of having a CVD risk factor was 25% lower for those in the moderately active group (OR = 0.75; 95% CI 0.64-0.88) and 30% lower for those in the high active group (OR = 0.70; 95% CI 0.6-0.81). CONCLUSION: Low active survivors appear to be at a high risk of CVD-related comorbidity. IMPLICATIONS FOR CANCER SURVIVORS: PA is associated with lower CVD-related comorbidity in CS, suggesting that interventions directed at increasing PA should be implemented to improve long-term health outcomes.
Authors: Giuseppe Curigliano; Daniela Cardinale; Susan Dent; Carmen Criscitiello; Olexiy Aseyev; Daniel Lenihan; Carlo Maria Cipolla Journal: CA Cancer J Clin Date: 2016-02-26 Impact factor: 508.702
Authors: Eric J Chow; Beth A Mueller; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Paul J Martin; Debra L Friedman; Stephanie J Lee Journal: Ann Intern Med Date: 2011-07-05 Impact factor: 25.391
Authors: William L Haskell; I-Min Lee; Russell R Pate; Kenneth E Powell; Steven N Blair; Barry A Franklin; Caroline A Macera; Gregory W Heath; Paul D Thompson; Adrian Bauman Journal: Med Sci Sports Exerc Date: 2007-08 Impact factor: 5.411
Authors: Sadeer G Al-Kindi; Ghaith F Abu-Zeinah; Chang H Kim; Vittal Hejjaji; Basem M William; Paolo F Caimi; Guilherme H Oliveira Journal: Clin Lymphoma Myeloma Leuk Date: 2015-08-05
Authors: Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Patrick T Bradshaw; June Stevens; Nikhil Khankari; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon Journal: Epidemiology Date: 2016-01 Impact factor: 4.822
Authors: Sarah J Hardcastle; Maddison Galliott; Brigid M Lynch; Nga H Nguyen; Paul A Cohen; Ganendra Raj Mohan; Niloufer J Johansen; Christobel Saunders Journal: Int J Behav Med Date: 2019-10
Authors: Alejandro Santos-Lozano; Javier Ramos; Alejandro Alvarez-Bustos; Blanca Cantos; Lidia B Alejo; Itziar Pagola; Ana Soria; Constanza Maximiano; Carmen Fiuza-Luces; Luisa Soares-Miranda; Alejandro Lucia; Ana Ruiz-Casado Journal: Support Care Cancer Date: 2018-02-05 Impact factor: 3.603
Authors: Lixin Song; Ting Guan; Peiran Guo; Thomas C Keyserling; Courtney Van Houtven; Xianming Tan Journal: J Cancer Surviv Date: 2019-08-22 Impact factor: 4.442
Authors: Sarah J Hardcastle; Chloe Maxwell-Smith; Sviatlana Kamarova; Stephanie Lamb; Lesley Millar; Paul A Cohen Journal: Support Care Cancer Date: 2017-10-31 Impact factor: 3.603
Authors: Sarah J Hardcastle; Robert Kane; Paola Chivers; Dana Hince; Andrew Dean; Dominic Higgs; Paul A Cohen Journal: Support Care Cancer Date: 2018-05-08 Impact factor: 3.603
Authors: Daniela Schmid; Gundula Behrens; Hannah Arem; Christina Hart; Wolfgang Herr; Carmen Jochem; Charles E Matthews; Michael F Leitzmann Journal: PLoS One Date: 2018-01-31 Impact factor: 3.240